Michael J. Vasconcelles, MD

Sturdy Memorial HospitalAttleboro, Massachusetts - 02703 (617-632-5301) |
- CLINICAL TRIALS 5
- CONDITIONS9
- INTERVENTIONS23
- SINCE2005

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
April 2008 - January 2010

Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
December 2008 - June 2010

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
August 2008 - August 2013

Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer
October 2005 - February 2008
Breast Neoplasms
Lung Neoplasms
Head and Neck Neoplasms
Carcinoma, Non-Small-Cell Lung
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
Demyelinating Diseases
Polyneuropathies
Neurologic Manifestations
Placebo
Immunohistochemistry Staining Method
Laboratory Biomarker Analysis
Study Of Socioeconomic And Demographic Variables
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Gene Expression Analysis
Polymorphism Analysis
Cyclophosphamide
Doxorubicin Hydrochloride
Polymerase Chain Reaction
Trastuzumab
Lapatinib Ditosylate
Mutation Analysis
Study Of High Risk Factors
Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
Ac Regimen
Duloxetine Hydrochloride
Chromogenic In Situ Hybridization
Fluorescent Antibody Technique



